Cargando…

Metastatic MEN1 Syndrome Treated with Lutetium-177 – A Case Report

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant endocrine tumour syndrome characterised by three main manifestations: primary hyperparathyroidism (78–94%), gastroenteropancreatic neuroendocrine tumours (GEP-NETs) (35–78%) and pituitary adenomas (20–65%). For metastatic and inoper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gezer, Emre, Çetinarslan, Berrin, Cantürk, Zeynep, Tarkun, İIlhan, Sözen, Mehmet, Selek, Alev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Touch Medical Media 2019
Materias:	Endocrine Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785959/ https://www.ncbi.nlm.nih.gov/pubmed/31616499 http://dx.doi.org/10.17925/EE.2019.15.2.92

Ejemplares similares

Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report
por: Gezer, Emre, et al.
Publicado: (2019)

Brentuximab vedotin-associated diabetic ketoacidosis: a case report
por: Köksalan, Damla, et al.
Publicado: (2022)

Pancreatic tumor with hepatic metastases secreting vasoactive intestinal polypeptide: Treatment options and long-term follow-up results
por: Sözen, Mehmet, et al.
Publicado: (2023)

Primary hypothalamic lymphoma with clinical findings mimicking pituitary apoplexy: a case report
por: Sözen, Mehmet, et al.
Publicado: (2021)

Differentiation of insulinoma from accessory spleen by (99m)Tc-labelled heat-denaturated red blood cell scintigraphy: case report
por: Gezer, Emre, et al.
Publicado: (2021)

Cushing’s disease due to a pituitary adenoma as a component of collision tumor: A case report and review of the literature
por: Gezer, Emre, et al.
Publicado: (2020)

Infiltration of thyroid papillary cancer tissue with myeloid leukemic cells: a case report
por: Sözen, Mehmet, et al.
Publicado: (2021)

The association of bone mineral density Z-score with the early postoperative remission and characteristics of bone mineral loss in patients with Cushing’s disease: a retrospective study
por: Gezer, Emre, et al.
Publicado: (2022)

Awareness of influenza and pneumococcal vaccines in diabetic patients
por: Sözen, Mehmet, et al.
Publicado: (2021)

Xanthomatous Hypophysitis Secondary to a Ruptured Rathke’s Cleft Cyst: A Case Report
por: Gezer, Emre, et al.
Publicado: (2022)

Xanthomatous sypophysitis secondary to a ruptured Rathke's cleft cyst
por: Gezer, Emre, et al.
Publicado: (2023)

The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli
por: Selek, Alev, et al.
Publicado: (2021)

The Utility of Preoperative ACTH/Cortisol Ratio for the Diagnosis and Prognosis of Cushing's Disease
por: Selek, Alev, et al.
Publicado: (2018)

The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus
por: Akyay, Ozlem Zeynep, et al.
Publicado: (2023)

Association of ultrasonographically determined anatomical location of Bethesda 3 thyroid nodules with differentiated thyroid cancer
por: Gezer, Emre, et al.
Publicado: (2022)

Lutetium-177 Dotatate-Induced Hemolytic Anemia and Myelodysplastic Syndrome
por: Alkassis, Samer, et al.
Publicado: (2022)

SHDB mutant functional metastatic paraganglioma: The efficacy of Lutetium-177 DOTATE
por: Erturk, Banu, et al.
Publicado: (2023)

Treatment of Advanced Metastatic Prostate Cancer Using Molecular-Targeted Therapy: Radioligand Lutetium-177 Prostate-Specific Membrane Antigen
por: Rathore, Rajni, et al.
Publicado: (2023)

Challenges and future options for the production of lutetium-177
por: Vogel, W. V., et al.
Publicado: (2021)

Lutetium Lu-177 Dotatate Flare Reaction
por: Salner, Andrew L., et al.
Publicado: (2020)

Inter-comparison of quantitative imaging of lutetium-177 ((177)Lu) in European hospitals
por: Wevrett, Jill, et al.
Publicado: (2018)

Circulating Tumour DNA Biomarkers Associated with Outcomes in Metastatic Prostate Cancer Treated with Lutetium-177-PSMA-617
por: Crumbaker, Megan, et al.
Publicado: (2023)

A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer
por: Alam, Mohammad R, et al.
Publicado: (2022)

Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer
por: Gadot, Moran, et al.
Publicado: (2020)

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2021)

Lutetium-177-PSMA-617: A Vision of the Future
por: Chandran, Elias, et al.
Publicado: (2022)

Lutetium Lu 177 Vipivotide Tetraxetan: First Approval
por: Keam, Susan J.
Publicado: (2022)

Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals
por: Ladrière, Typhanie, et al.
Publicado: (2023)

Lutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System
por: Aslani, Alireza, et al.
Publicado: (2015)

Neuroendocrine Tumor Therapy with Lutetium-177: A Literature Review
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

(177)Lutetium SPECT/CT: Evaluation of collimator, photopeak and scatter correction
por: Huizing, Daphne M. V., et al.
Publicado: (2020)

Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy
por: Cappon, Derek John, et al.
Publicado: (2023)

Lutetium-177 Prostate Specific Membrane Antigen Therapy in a Patient With Double Malignancy and Single Functioning Kidney: A Case Report
por: Naeem, Zikriya, et al.
Publicado: (2023)

Role of Mitotane in Adrenocortical Carcinoma – Review and State of the art
por: Paragliola, Rosa Maria, et al.
Publicado: (2018)

Primary Leiomyosarcoma of the Thyroid Gland – A Rare Malignancy
por: Reddy, Bhasker, et al.
Publicado: (2019)

A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?
por: Boharoon, Hessa, et al.
Publicado: (2022)

Surgical Treatment of Solitary Metachronous Adrenal Metastasis from Urothelial Carcinoma of the Urinary Bladder
por: Politis, Dimitrios, et al.
Publicado: (2023)

MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2020)

Definitive Treatment of Brain Metastases From a Neuroendocrine Tumor With Peptide Receptor Radionuclide Therapy With 177Lutetium DOTATATE: A Case Report
por: Zhang, Vivian, et al.
Publicado: (2023)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3sgl2cblievti3g2efeh5a24c8